مقالة · مجلة · 2007

Is it worth using daclizumab induction therapy with mycophenolate mofetil-based immunosuppressive regimens in live related donor kidney transplantation? A long-term follow up

Hussein A Sheashaa, Mohamed A. Bakr, Mohamed Ashraf Fouda, Khalid F. El-dahshan, A. M. Ismail, Mohammed Sobh و1 آخرون

International Urology and Nephrology

• وصول مغلق

انتقل إلى الناشر10.1007/s11255-006-9091-8